ALLMedicine™ Primary Pulmonary Hypertension Center
Research & Reviews 128 results
https://clinicaltrials.gov/ct2/show/NCT00098072
Jun 24th, 2022 - Introduction: Primary pulmonary hypertension, now known as idiopathic pulmonary arterial hypertension (IPAH), a subgroup of pulmonary arterial hypertension (PAH), is a rare disorder characterized by severe morbidity and high mortality rates. There...
https://emedicine.medscape.com/article/301450-print
May 27th, 2022 - Practice Essentials Idiopathic pulmonary arterial hypertension (IPAH) is a rare disease characterized by elevated pulmonary artery pressure with no apparent cause. IPAH is also termed WHO Group I pulmonary hypertension (PH), precapillary pulmonary...
https://emedicine.medscape.com/article/301450-overview
May 27th, 2022 - Practice Essentials Idiopathic pulmonary arterial hypertension (IPAH) is a rare disease characterized by elevated pulmonary artery pressure with no apparent cause. IPAH is also termed WHO Group I pulmonary hypertension (PH), precapillary pulmonary...
http://emedicine.medscape.com/article/301450-overview
May 27th, 2022 - Practice Essentials Idiopathic pulmonary arterial hypertension (IPAH) is a rare disease characterized by elevated pulmonary artery pressure with no apparent cause. IPAH is also termed WHO Group I pulmonary hypertension (PH), precapillary pulmonary...
https://clinicaltrials.gov/ct2/show/NCT00678821
May 19th, 2022 - We propose a randomized trial to determine the safety and effectiveness of aerobic exercise for patients who have primary pulmonary hypertension (PH) or PH secondary to interstitial lung disease (ILD). This project will be the first in a series of...
Drugs 4 results see all →
Clinicaltrials.gov 32 results
https://clinicaltrials.gov/ct2/show/NCT00098072
Jun 24th, 2022 - Introduction: Primary pulmonary hypertension, now known as idiopathic pulmonary arterial hypertension (IPAH), a subgroup of pulmonary arterial hypertension (PAH), is a rare disorder characterized by severe morbidity and high mortality rates. There...
https://clinicaltrials.gov/ct2/show/NCT00678821
May 19th, 2022 - We propose a randomized trial to determine the safety and effectiveness of aerobic exercise for patients who have primary pulmonary hypertension (PH) or PH secondary to interstitial lung disease (ILD). This project will be the first in a series of...
https://clinicaltrials.gov/ct2/show/NCT05251987
Feb 23rd, 2022 - Myocardial infarction is a serious common disease in human beings. Although many patients with acute myocardial infarction survive with the improvement of medical technology in recent years, studies have shown that cardiac remodeling caused by myo...
https://clinicaltrials.gov/ct2/show/NCT03310229
Jan 20th, 2021 - Primary whose mechanisms are incompletely known, is another vascular disease entity recently described in chronic kidney disease particularly in patients undergoing haemodialysis. It corresponds to 5th subtype of World Symposium on Pulmonary Hyper...
https://clinicaltrials.gov/ct2/show/NCT04058132
Aug 19th, 2019 - Background and significance: Currently, more that 5.3 million Americans (or 2% of the population) live with disabilities resulting from TBI. Among OEF/OIF Veterans, TBI incidence estimates as high as 23% have been reported, with mild TBI (mTBI) be...
News 13 results
https://www.medpagetoday.com/genetics/genetictesting/53088
Aug 16th, 2015 - I have looked into my genome and seen ... nothing much to worry about. I carry 15 rare genetic variants that have been associated with some form of disease, but I am heterozygous for all of them -- I have one intact copy of the same gene. So I car...
https://www.mdedge.com/dermatology/article/82448/lupus-connective-tissue-diseases/avenues-protecting-against-vasculopathy/page/0/1
May 19th, 2014 - Endothelin inhibitors Endothelin inhibitors also may play a role in vascular protection. Endothelin is secreted in scleroderma and is a potent vasoconstrictor.
https://www.medscape.com/viewarticle/762321_2
Apr 20th, 2012 - Answer Right ventricular hypertrophy Discussion In this tracing, QRS axis tends to the right axis deviation (RAD), which should make one think of right ventricular hypertrophy (RVH) first. After the RAD, all other diagnostic features of RVH are fo...
https://www.mdedge.com/familymedicine/article/46858/products-liability
Family Practice News;
Dec 29th, 2011 - Question: A woman developed primary pulmonary hypertension (PPH) 4 years after she had stopped using the prescription weight-loss drug, fenfluramine. The drug is known to cause valvular heart lesions as well as PPH.
https://www.staging.medscape.com/viewarticle/754137
Nov 28th, 2011 - November 28, 2011 (Chicago, Illinois) — Approximately half of the neonates who receive extracorporeal membrane oxygenation (ECMO) have cerebral atrophy. Magnetic resonance imaging (MRI) has shown that the N-acetylaspartate/creatine (NAA/Cr) ratio ...